Precision Medicine

Can IMVT-1402 Transform Sjögren’s Disease Treatment?
Research & Development Can IMVT-1402 Transform Sjögren’s Disease Treatment?

The management of primary Sjögren’s disease has historically been limited to symptomatic relief, leaving many patients to struggle with systemic complications that extend far beyond the hallmark dry eyes and dry mouth associated with the condition. This chronic autoimmune disorder involves the

New CA19-9 Threshold Improves Pancreatic Cancer Prognosis
Research & Development New CA19-9 Threshold Improves Pancreatic Cancer Prognosis

Pancreatic ductal adenocarcinoma remains one of the most formidable challenges in modern oncology, primarily because its symptoms are often masked until the disease has reached an advanced and nearly untreatable stage. For several decades, the medical community has utilized carbohydrate antigen

Can Neurophet and Dr. Tanenbaum Transform Neuroimaging?
Tech & Innovation Can Neurophet and Dr. Tanenbaum Transform Neuroimaging?

The global medical community is currently facing an unprecedented surge in neurodegenerative conditions, creating an urgent demand for diagnostic tools that move beyond traditional qualitative observations. As aging populations increase the prevalence of Alzheimer’s disease and other forms of

Does Mutation Severity Override Female Resilience in Autism?
Tech & Innovation Does Mutation Severity Override Female Resilience in Autism?

The persistent clinical observation that males are diagnosed with autism spectrum disorder at nearly four times the rate of females has remained one of the most enduring and complex enigmas in modern neurobiology. For decades, scientists have operated under the hypothesis of a female protective

How Can AI Design Quasisymmetric Protein Nanocages?
Tech & Innovation How Can AI Design Quasisymmetric Protein Nanocages?

Nature has perfected the art of molecular architecture over billions of years, creating viral capsids that serve as the gold standard for structural efficiency and protective capability. These biological shells are composed of hundreds or even thousands of identical protein subunits that

Can a Global Clinical Trial Stop This Rare Brain Disease?
Research & Development Can a Global Clinical Trial Stop This Rare Brain Disease?

The diagnosis of a rare neurodegenerative condition often leaves families in a state of profound uncertainty as they navigate a medical landscape with few answers and even fewer treatment options. For David Booth, a retired builder from the United Kingdom, the journey began not with a sudden

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later